Venn Life Sciences Holdings (VENN)

 

VENN Share PerformanceMore

52 week high30.300 03/08/16
52 week low13.000 20/07/17
52 week change -12.250 (-47.12%)
4 week volume1,524,269 29/06/17

Technical Insight

Login or Register to access technical insights.

Latest NewsMore

Senior Management Appointment

RNS Number: 9357L Venn Life Sciences Holdings PLC 25 July 2017 Venn Life Sciences Holdings Plc ("Venn" or the "Company" or the "Group") Senior Management Appointment Venn Life Sciences (AIM: VENN), a growing Contract Research Organisation providing drug development, clinical trial management and resourcing solutions to pharmaceutical, biotechn...

Venn Life Sciences reports strong start to 2017

Venn Life Sciences announced the new financial year started well with contract wins of 5.7m secured in January and Feb...

Half year end update

RNS Number: 5675L Venn Life Sciences Holdings PLC 20 July 2017 Venn Life Sciences Holdings Plc ("Venn" or the "Company" or the "Group") Half year end update Venn Life Sciences (AIM: VENN), a growing Contract Research Organisation providing drug development, clinical trial management and resourcing solutions to pharmaceutical, biotechnology and m...

Result of AGM

RNS Number: 4690D Venn Life Sciences Holdings PLC 26 April 2017 26 April 2017 Venn Life Sciences Holdings Plc ("Venn" or the "Company") Result of Annual General Meeting Venn Life Sciences Holdings plc (AIM: VENN), a growing Contract Research Organisation (CRO) providing drug development, clinical trial management and resourcing solutions to phar...

Proposed amendment to AGM resolution

RNS Number: 3003D Venn Life Sciences Holdings PLC 25 April 2017 25 April 2017 Venn Life Sciences Holdings Plc ("Venn" or the "Company") AGM update Proposed amendment to resolution to be considered at AGM Venn Life Sciences Holdings plc (AIM: VENN), a growing Contract Research Organisation (CRO) providing drug development, clinical trial manag...

Integumen IPO

RNS Number: 5942B Venn Life Sciences Holdings PLC 05 April 2017 5 April 2017 Venn Life Sciences Holdings Plc ("Venn" or the "Company") IPO of Integumen plc Venn Life Sciences (AIM: VENN), a growing Contract Research Organisation (CRO) providing drug development, clinical trial management and resourcing solutions to pharmaceutical, biotechnology a...

Enterprise Securities Market Notice

RNS Number: 9358A Irish Stock Exchange 04 April 2017 REPORT OF THE BOARD OF THE IRISH STOCK EXCHANGE Irish Stock Exchange 28 Anglesea Street DUBLIN 2 4 th April 2017 ESM ADMISSION NOTICE The Board of the Irish Stock Exchange approves admission of the under-mentioned security to trading on the Enterprise Securities Market. Venn L...

Annual Financial Report & Notice of AGM

RNS Number: 1795B Venn Life Sciences Holdings PLC 31 March 2017 31 March 2017 Venn Life Sciences Holdings Plc ("Venn" or the "Company") Posting of Annual Report & Notice of AGM Venn Life Sciences (AIM: VENN), a growing Contract Research Organisation (CRO) providing drug development, clinical trial management and resourcing solutions to pharm...

Equity Research (VENN)

Venn Life Sciences Holdings plc
20/07/2017
After a lacklustre full year results released in March 2017, the growing Contract Research Organisation providing drug development, clinical trial management and resourcing solutions to...
Venn Life Sciences Holdings plc
31/03/2017
Venn’s full year results last week highlighted some of the growing pains associated with high growth companies and bedding down significant acquisitions. The impressive 57% top line growth was...
Venn Life Sciences Holdings plc
22/03/2017
The growing Contract Research Organisation (CRO) providing drug development, clinical trial management and resourcing solutions to pharmaceutical, biotechnology and medical device clients has...

Latest discussion posts More

  • New Hybridan note

    Hybridan brought out a new note on Thursday envisaging a 30p+ share price on delivery of 2017 forecasts (against the current 13.75p). Their forecasts are: this year : ...
    24-Jul-2017
    gretel
  • Decent H1 trading statement

    Pretty good H1 trading statement, in particular expressing confidence going forward. Note the ?2.9m cash against the #9m ...
    20-Jul-2017
    gretel
  • New update from Davy Stockbrokers

    Davy Stockbrokers issued a positive update on VENN last week. It's client-only, but there's a summary ...
    19-Apr-2017
    gretel

Users' HoldingsMore

Users who hold Venn Life Sciences Holdings also hold..
APC TECHNOLOGY22%
ROCKHOPPER16%
REDSTONECON16%
AMINO TECH16%
D4T4 SOLUTIONS11%

Codes & Symbols

ISINGB00B9275X97
SymbolsVENN, LSE:VENN, VENN.L, VENN:LN, LON:VENN, XLON:VENN